METHOD FOR PREDICTING VULVA CANCER TREATMENT RESULTS

摘要

medicine. SUBSTANCE: method involves examining vulva cancer patients belonging to III clinical group in dynamic mode after applying antitumor treatment. Daily melatonin excretion is determined in urine. Marked daily melatonin level increase, 2-3 times as large when compared to a reference value, being observed, vulva cancer recurrence is predicted to take place in 2-4 months. EFFECT: enhanced reliability of prognosis.